[Results of treatment of experimental toxoplasmosis in albino mice with some chemothrapeutic agents].
D000208:Acute Disease; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D002751:Chlortetracycline / Q000627:therapeutic use; D004357:Drug Synergism; D015643:Erythromycin Ethylsuccinate / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use*; D051379:Mice; D011739:Pyrimethamine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D013418:Sulfamethazine / Q000627:therapeutic use*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000401:mortality
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D000981:Antiprotozoal Agents; D007093:Imidazoles; D011804:Quinolines; D015643:Erythromycin Ethylsuccinate; D013418:Sulfamethazine; D002738:Chloroquine; D002751:Chlortetracycline; D011739:Pyrimethamine
Rezul'taty lecheniia éksperimenatl'nogo toksoplazmoza belykh mtsheĭ nekotorymi khimioterapevticheskimi preparatami.